表紙
市場調查報告書
商品編碼
1028631

全球霧化器市場規模,佔有率,COVID-19的影響分析:2021∼2027年:各設備類型(壓縮機/噴氣式飛機,及震動式)

Nebulizer Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by Device Type: Compressor/Jet, and Vibrating

出版日期: | 出版商: iData Research Inc. | 英文 | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球霧化器的市場規模,2020年因COVID-19受正面的影響,在預測期間內預計也以0.7%的年複合成長率擴大繼續成長,2027年預計達到3億2,180萬美元。

全球霧化器市場佔有率,大部分由OMRON,PARI,Philips Healthcare所佔。

霧化器,是一種用於在呼吸系統疾病(如哮喘或囊性纖維化)導致肺損傷時輔助呼吸的裝置。霧化器市場通常針對使用標準哮喘吸入器有困難的人使用哮喘藥物。

本報告提供全球霧化器市場相關調查,市場概要,以及市場規模與至2027年的成長預測,市場成長的推動要素與阻礙因素,及加入此市場的主要企業競爭情形等資訊。

目錄

  • 銷售台數,平均銷售價格,市場規模與成長趨勢
  • COVID-19的影響分析
  • 市場促進因素與阻礙因素
  • 至2027年的市場預測,及2017年前的成果資料
  • 最近的企業合併、收購情形
  • 企業簡介和產品系列
  • 主要的其他競爭公司
目錄
Product Code: iDATA_GLARS21_MC_NM

Throughout this medical market research, the publisher analyzed Nebulizer companies across more than 70 countries and used their comprehensive methodology to understand the Market Sizes, Unit Sold, Average Selling Prices, Company Market Shares, and to create Accurate Forecasts.

The global nebulizer market was influenced in a positive way by COVID-19 in 2020 and is expected to continue growing over the forecast period to reach $321.8 million at a CAGR of 0.7% by 2027.

The majority of the global nebulizer market share was controlled by Omron, PARI, and Philips Healthcare.

A nebulizer is a piece of equipment used to assist breathing when the lung is affected by diseases such as asthma, cystic fibrosis, and other respiratory conditions. The market for nebulizers typically corresponds to the delivery of asthma medications to anyone who has difficulty using a standard asthma inhaler. This global market research spans over 70 countries and includes compressor/jet nebulizers and vibrating nebulizers.

MARKET DATA INCLUDED:

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

NEBULIZER MARKET INSIGHTS

Within this market, compressor variations represented the vast majority of the units sold, as they are inexpensive devices. While their higher price points can deter some customers, the ultrasonic and vibrating mesh variations have benefits that are gaining recognition, therefore stimulating growth in the market. COVID-19 did not have as significant an impact on the nebulizer market as it did on other segments, but it still did have a positive effect, resulting in double-digit growth in 2020.

NEBULIZER MARKET SHARE INSIGHTS

The global ventilator market was controlled by Omron, PARI, and Philips Healthcare.

Omron was the leading competitor in the total nebulizer market, with popular offerings in the ultrasonic nebulizer and vibrating mesh nebulizer markets. The company's Micro Air® NE-U100 device is one of the smallest vibrating mesh nebulizers available on the market, making it a convenient alternative to metered-dose inhalers.

RESEARCH REGIONAL COVERAGE

Throughout this report, iData Research has covered over 70 countries across the globe in great detail. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)